Homburger advised Idorsia Ltd in connection with its new up to CHF 250 m secured financing

On June 9, 2026, Idorsia Ltd (SIX: IDIA), a commercial-stage biopharmaceutical company with a portfolio of first- or best-in-class assets, entered into a senior secured term loan agreement of up to CHF 250 million with investment funds managed by Pharmakon Advisors, LP. The first tranche of CHF 150 million will be used, among other things, to refinance existing financing of the Idorsia group, with further tranches available, subject to customary conditions, to support targeted initiatives to accelerate growth and long‑term value creation.

Homburger advised Idorsia Ltd on the Swiss law aspects of the transaction.

The Homburger team was led by Frank Gerhard and included Eduard De Zordi and Daniel Hulmann (all Capital Markets).